LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

Home・Aktien・Abbott Laboratories

Abbott Laboratories

Geschlossen

BrancheGesundheitswesen

84.24 -3.13

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

84.08

Max

87.23

Schlüsselkennzahlen
By Trading Economics
Einkommen	-699M 1.1B
Verkäufe	-295M 11B
KGV Branchendurchschnitt	25.083 49.8
EPS	1.15
Dividendenrendite	2.73
Gewinnspanne	9.647
Angestellte	122,000
EBITDA	-980M 1.8B

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+38.19% upside

Dividenden
By Dow Jones
Dividendenrendite Branchendurchschnitt	2.73% 2.25%
Nächstes Ergebnis	16. Juli 2026
Nächste Dividendenausschüttung	15. Mai 2026
Nächstes Ex-Dividendendatum	14. Juli 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-22B 152B
Vorheriger Eröffnungskurs	87.37
Vorheriger Schlusskurs	84.24

Nachrichtenstimmung

By Acuity

41%

59%

156 / 347 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Weak Bullish Evidence

132.82 / 134.43 Unterstützung & Widerstand

Abbott Laboratories Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Peer-Vergleich

Kursveränderung

Abbott Laboratories Prognose

Kursziel

By TipRanks

38.19% Vorteil

12-Monats-Prognose

Durchschnitt 120.24 USD 38.19%

Hoch 143 USD

Tief 92 USD

Basierend auf 20 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Abbott Laboratories – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

20 ratings

Buy

Halten

Sell

Basierend auf 20 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Abbott Laboratories – Dist abgegeben haben.

Technischer Score

By Trading Central

132.82 / 134.43Unterstützung & Widerstand

Bullish events outweigh bearish events.

The bullish and bearish events are balanced.

All events are bullish.

Stimmung

By Acuity

156 / 347 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.